Global Pharmaceutical Safety Assessment Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : November 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Pharmaceutical Safety Assessment Global Market Report 2025

Name: Pharmaceutical Safety Assessment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment), By Drug Type (Biological Drugs, Chemical Drugs), By Phase (Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)), By End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pharmaceutical Safety Assessment Market Overview

• Pharmaceutical Safety Assessment market size has reached to $10.47 billion in 2024

• Expected to grow to $15.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%

• Growth Driver: Expansion Of Clinical Trials Is Fueling Market Growth Due To Increasing Demand For Drug Safety Assessment

• Market Trend: AI-Driven Platforms Enhancing Accuracy And Efficiency In Toxicity Prediction

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceutical Safety Assessment Market?

The main types in the pharmaceutical safety assessment market are in-vitro safety assessment, in-vivo safety assessment, and computational safety assessment. In-vitro safety assessment refers to the evaluation of the safety and toxicity of drugs, chemicals, or other substances using controlled laboratory tests performed outside of a living organism. The various types of drugs include biological drugs and chemical drugs. It spans multiple phases, such as preclinical, clinical (phase I, II, III), and post-market surveillance (phase IV). Key end users include pharmaceutical companies, biotechnology firms, medical device manufacturers, academic and research institutions, and contract research organizations (CROs).

Pharmaceutical Safety Assessment Market Size and growth rate 2025 to 2029: Graph

What Is The Pharmaceutical Safety Assessment Market Growth Forecast?

The pharmaceutical safety assessment market size is expected to see strong growth in the next few years. It will grow to $15.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to expansion of biologics and biosimilars development, increasing adoption of in-silico toxicology platforms, rising investment in personalized medicine, regulatory shift toward alternative testing methods, growing demand for high-throughput screening technologies. Major trends in the forecast period include integration of artificial intelligence in toxicity prediction, shift from animal testing to organ-on-chip systems, expansion of computational modeling for safety profiling, rising collaborations between pharma and tech firms, focus on predictive biomarkers for safety assessment.

What Is The Pharmaceutical Safety Assessment Market Size 2025 And Growth Rate?

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Pharmaceutical Safety Assessment Market Segmented?

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

What Is Driving The Pharmaceutical Safety Assessment Market? Expansion Of Clinical Trials Is Fueling Market Growth Due To Increasing Demand For Drug Safety Assessment

The expansion of clinical trials is expected to propel the growth of the pharmaceutical safety assessment market going forward. Clinical trials refer to research studies conducted in humans to evaluate the safety, effectiveness, and side effects of new medical treatments, drugs, or interventions. Clinical trials are rising due to the growing need for new and effective treatments, as researchers and healthcare providers aim to develop therapies that can better prevent, manage, or cure diseases. Clinical trials support pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, determining safe dosage ranges, and providing essential data that regulatory authorities use to ensure that medications are both effective and safe for public use. For instance, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, as of September 26, 2025, a total of 554,798 studies were registered on ClinicalTrials.gov. Therefore, the expansion of clinical trials is driving the growth of the pharmaceutical safety assessment industry.

Who Are The Major Players In The Global Pharmaceutical Safety Assessment Market?

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

What Are The Key Trends Of The Global Pharmaceutical Safety Assessment Market? AI-Driven Platforms Enhancing Accuracy And Efficiency In Toxicity Prediction

Major companies in the pharmaceutical safety assessment market are focusing on developing AI-powered decision support tools to enhance the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is a software system that uses artificial intelligence to analyze data and provide insights that support faster and more accurate decision-making. For instance, in April 2024, Charles River Laboratories, a US-based life sciences company, in partnership with Deciphex, an Ireland-based company enhances diagnostic precision and speed through AI-driven quality assurance, launched the Patholytix Foresight platform, an AI-powered decision support tool, designed to transform toxicologic pathology in pharmaceutical safety assessment. The platform uses artificial intelligence to quickly analyze complex preclinical pathology data, helping identify potential safety risks earlier and reducing subjectivity in results. It offers unique features such as an AI algorithm that detects tissue abnormalities, a cloud-based system for global collaboration, and a scalable design that cuts down slide review time while improving data accuracy and consistency.

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Pharmaceutical Safety Assessment Market? ProductLife Group Acquires Stragen Services SAS to Strengthen Pharmacovigilance and European Presence

In January 2025, Groupe ProductLife S.A.S., a France-based life sciences services company, acquired Stragen Services SAS for an undisclosed amount. With this acquisition, ProductLife Group aims to enhance its pharmacovigilance and clinical safety capabilities, expand its European market presence, and provide more comprehensive regulatory and safety support to pharmaceutical and biotech clients. Stragen Services SAS is a France-based company that specializes in pharmaceutical safety assessment, also known as pharmacovigilance.

What Is The Regional Outlook For The Global Pharmaceutical Safety Assessment Market?

North America was the largest region in the pharmaceutical safety assessment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the the pharmaceutical safety assessment market market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical safety assessment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Safety Assessment Market?

The pharmaceutical safety assessment market includes revenues earned by entities by providing services such as post-marketing surveillance, safety pharmacology, regulatory consulting and compliance, bioanalytics and biomarker services, and in silico and computational toxicology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharmaceutical Safety Assessment Industry?

The pharmaceutical safety assessment market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical safety assessment market statistics, including pharmaceutical safety assessment industry global market size, regional shares, competitors with a pharmaceutical safety assessment market share, detailed pharmaceutical safety assessment market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical safety assessment industry. This pharmaceutical safety assessment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

1. Executive Summary

2. Pharmaceutical Safety Assessment Market Characteristics

3. Pharmaceutical Safety Assessment Market Trends And Strategies

4. Pharmaceutical Safety Assessment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pharmaceutical Safety Assessment Growth Analysis And Strategic Analysis Framework

5.1. Global Pharmaceutical Safety Assessment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pharmaceutical Safety Assessment Market Growth Rate Analysis

5.4. Global Pharmaceutical Safety Assessment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pharmaceutical Safety Assessment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pharmaceutical Safety Assessment Total Addressable Market (TAM)

6. Pharmaceutical Safety Assessment Market Segmentation

6.1. Global Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In-Vitro Safety Assessment

In-Vivo Safety Assessment

Computational Safety Assessment

6.2. Global Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biological Drugs

Chemical Drugs

6.3. Global Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical

Clinical (Phase I, II, III)

Post-Market Surveillance (Phase IV)

6.4. Global Pharmaceutical Safety Assessment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biotechnology Companies

Medical Device Companies

Academic And Research Institutions

Contract Research Organizations (CROs)

6.5. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vitro Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell-Based Assays

Organotypic Models

Tissue Culture Models

High-Throughput Screening

6.6. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vivo Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rodent Studies

Non-Rodent Studies

Toxicokinetic Studies

Carcinogenicity Studies

6.7. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of Computational Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Quantitative Structure-Activity Relationship Modeling

Physiologically Based Pharmacokinetic Modeling

Toxicity Prediction Software

In Silico Simulation Studies

7. Pharmaceutical Safety Assessment Market Regional And Country Analysis

7.1. Global Pharmaceutical Safety Assessment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pharmaceutical Safety Assessment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Safety Assessment Market

8.1. Asia-Pacific Pharmaceutical Safety Assessment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Safety Assessment Market

9.1. China Pharmaceutical Safety Assessment Market Overview

9.2. China Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Safety Assessment Market

10.1. India Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Safety Assessment Market

11.1. Japan Pharmaceutical Safety Assessment Market Overview

11.2. Japan Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Safety Assessment Market

12.1. Australia Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Safety Assessment Market

13.1. Indonesia Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Safety Assessment Market

14.1. South Korea Pharmaceutical Safety Assessment Market Overview

14.2. South Korea Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Safety Assessment Market

15.1. Western Europe Pharmaceutical Safety Assessment Market Overview

15.2. Western Europe Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Safety Assessment Market

16.1. UK Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Safety Assessment Market

17.1. Germany Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Safety Assessment Market

18.1. France Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Safety Assessment Market

19.1. Italy Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Safety Assessment Market

20.1. Spain Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Safety Assessment Market

21.1. Eastern Europe Pharmaceutical Safety Assessment Market Overview

21.2. Eastern Europe Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Safety Assessment Market

22.1. Russia Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Safety Assessment Market

23.1. North America Pharmaceutical Safety Assessment Market Overview

23.2. North America Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Safety Assessment Market

24.1. USA Pharmaceutical Safety Assessment Market Overview

24.2. USA Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Safety Assessment Market

25.1. Canada Pharmaceutical Safety Assessment Market Overview

25.2. Canada Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Safety Assessment Market

26.1. South America Pharmaceutical Safety Assessment Market Overview

26.2. South America Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Safety Assessment Market

27.1. Brazil Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Safety Assessment Market

28.1. Middle East Pharmaceutical Safety Assessment Market Overview

28.2. Middle East Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Safety Assessment Market

29.1. Africa Pharmaceutical Safety Assessment Market Overview

29.2. Africa Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Safety Assessment Market Competitive Landscape And Company Profiles

30.1. Pharmaceutical Safety Assessment Market Competitive Landscape

30.2. Pharmaceutical Safety Assessment Market Company Profiles

30.2.1. IQVIA Holding Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. LabCorp (formerly Covance) Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific (PPD) Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Safety Assessment Market Other Major And Innovative Companies

31.1. Parexel International Corp.

31.2. Syneos Health

31.3. Eurofins Scientific SE

31.4. Wuxi Biologics Inc.

31.5. SGS SA

31.6. Medpace Holdings Inc.

31.7. Fujifilm Wako (Fujifilm Corp.)

31.8. Pharmaron Beijing Co. Ltd.

31.9. Inotiv (incl. Envigo)

31.10. Evotec (Cyprotex)

31.11. Intertek Group

31.12. Altasciences Inc.

31.13. Aragen Life Sciences Ltd.

31.14. CTI Clinical Trial and Consulting Inc.

31.15. ChemDiv Inc.

32. Global Pharmaceutical Safety Assessment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Safety Assessment Market

34. Recent Developments In The Pharmaceutical Safety Assessment Market

35. Pharmaceutical Safety Assessment Market High Potential Countries, Segments and Strategies

35.1 Pharmaceutical Safety Assessment Market In 2029 - Countries Offering Most New Opportunities

35.2 Pharmaceutical Safety Assessment Market In 2029 - Segments Offering Most New Opportunities

35.3 Pharmaceutical Safety Assessment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Pharmaceutical Safety Assessment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vitro Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vivo Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of Computational Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Pharmaceutical Safety Assessment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Pharmaceutical Safety Assessment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: IQVIA Holding Inc. Financial Performance

Table 79: LabCorp (formerly Covance) Financial Performance

Table 80: Thermo Fisher Scientific (PPD) Financial Performance

Table 81: Charles River Laboratories Financial Performance

Table 82: ICON plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Pharmaceutical Safety Assessment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vitro Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vivo Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of Computational Safety Assessment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Pharmaceutical Safety Assessment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Pharmaceutical Safety Assessment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: IQVIA Holding Inc. Financial Performance

Figure 79: LabCorp (formerly Covance) Financial Performance

Figure 80: Thermo Fisher Scientific (PPD) Financial Performance

Figure 81: Charles River Laboratories Financial Performance

Figure 82: ICON plc Financial Performance

Antiobesity Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Antiobesity Market Landscape: Innovative Advancements In The Anti-Parkinson Drugs Market

Top Trends Driving Innovation and Change in the Anti-Thyroid Drugs Market: Raising Awareness And Promoting Thyroid Health In The Anti-Thyroid Drug Market

Market Trends Influencing Strategic Decisions in the Antivirals Industry: Innovative Oral Antiviral Treatments Enhancing Patient Compliance And Accessibility In The Fight Against Viral Infections

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Email Deliverability Tools Global Market Report 2025 – By Type (Email Validation Tools, Email Authentication Tools, Email Reputation Tools, Other Types), By Deployment Model (Cloud, On-Premises), By Application (Large En...

View Report

Radome Global Market Report 2025 – By Type (Shell Structure, Spherical Structure), By Offering Type (Radome Body, Accessories, Services), By Application (Airborne Radome, Ground-Based Radome, Shipboard Radome) – Impact o...

View Report

Preparation of Coffee Extracts Global Market Report 2025 – By Product Type (Capsules Or Tablets, Powder, Liquid Green Coffee Bean Extraction, Chews), By Source Type (Green Coffee Beans, Roasted Coffee Beans), By Nature T...

View Report

Musical Instruments Global Market Report 2025 – By Type (Stringed, Brass And Woodwind, Percussion, Keyboard), By Distribution Channel (Supermarkets\ Hypermarkets, Specialty Stores, Online Sales Channel), By Application (...

View Report

Factory Buildings Global Market Report 2025 – By Type (Residential, Non-residential), By Material (Aggregates, Bricks, Cement ), By Construction Type (New Construction, Renovation), By Application (Owned, Rental ), By En...

View Report

Liraglutide Global Market Report 2025 – By Brands (Victoza, Saxenda), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies), By Type Of Application (Diabetes Treatment, Weigh...

View Report

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

View Report

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

View Report

Frequently Asked Questions

What is the definition of the Pharmaceutical Safety Assessment market?

Pharmaceutical safety assessment is the systematic evaluation of drugs and pharmaceutical products to ensure their safety and minimize potential risks to patients. It involves analyzing preclinical and clinical data, monitoring adverse effects, and ensuring compliance with regulatory standards. This process helps in making informed decisions regarding the approval, labeling, and safe use of medications. The main types in the pharmaceutical safety assessment market are in-vitro safety assessment, in-vivo safety assessment, and computational safety assessment. In-vitro safety assessment refers to the evaluation of the safety and toxicity of drugs, chemicals, or other substances using controlled laboratory tests performed outside of a living organism. The various types of drugs include biological drugs and chemical drugs. It spans multiple phases, such as preclinical, clinical (phase I, II, III), and post-market surveillance (phase IV). Key end users include pharmaceutical companies, biotechnology firms, medical device manufacturers, academic and research institutions, and contract research organizations (CROs). For further insights on this market, request a sample here

How will the Pharmaceutical Safety Assessment market drivers and restraints affect the market dynamics? What forces will shape the Pharmaceutical Safety Assessment industry going forward?

The market major growth driver - Expansion Of Clinical Trials Is Fueling Market Growth Due To Increasing Demand For Drug Safety Assessment. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Pharmaceutical Safety Assessment market?

The pharmaceutical safety assessment market size has grown strongly in recent years. It will grow from $10.47 billion in 2024 to $11.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising preclinical research demand, increasing regulatory requirements for drug safety, growth in outsourcing to contract research organizations, advancements in animal model studies, early adoption of cell-based assays. The pharmaceutical safety assessment market size is expected to see strong growth in the next few years. It will grow to $15.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to expansion of biologics and biosimilars development, increasing adoption of in-silico toxicology platforms, rising investment in personalized medicine, regulatory shift toward alternative testing methods, growing demand for high-throughput screening technologies. Major trends in the forecast period include integration of artificial intelligence in toxicity prediction, shift from animal testing to organ-on-chip systems, expansion of computational modeling for safety profiling, rising collaborations between pharma and tech firms, focus on predictive biomarkers for safety assessment. For further insights on this market, request a sample here

How is the Pharmaceutical Safety Assessment market segmented?

The pharmaceutical safety assessmentmarket covered in this report is segmented –
1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment
2) By Drug Type: Biological Drugs, Chemical Drugs
3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)
4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs) Subsegments:
1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening
2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies
3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies For further insights on this market, request a sample here

Which region has the largest share of the Pharmaceutical Safety Assessment market? What are the other regions covered in the report?

Who are the major players in the Pharmaceutical Safety Assessment market?

What are the key trends in the Pharmaceutical Safety Assessment market?

Major trends in this market include AI-Driven Platforms Enhancing Accuracy And Efficiency In Toxicity Prediction. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Pharmaceutical Safety Assessment Global Market Report 2025

Pharmaceutical Safety Assessment Market Overview

What Is Covered Under Pharmaceutical Safety Assessment Market?

What Is The Pharmaceutical Safety Assessment Market Growth Forecast?

What Is The Pharmaceutical Safety Assessment Market Size 2025 And Growth Rate?

What’s The Trade War Impact On Pharmaceuticals Industry?

How Is The Pharmaceutical Safety Assessment Market Segmented?

What Is Driving The Pharmaceutical Safety Assessment Market? Expansion Of Clinical Trials Is Fueling Market Growth Due To Increasing Demand For Drug Safety Assessment

Who Are The Major Players In The Global Pharmaceutical Safety Assessment Market?

What Are The Key Trends Of The Global Pharmaceutical Safety Assessment Market? AI-Driven Platforms Enhancing Accuracy And Efficiency In Toxicity Prediction

What Are Latest Mergers And Acquisitions In The Pharmaceutical Safety Assessment Market? ProductLife Group Acquires Stragen Services SAS to Strengthen Pharmacovigilance and European Presence

What Is The Regional Outlook For The Global Pharmaceutical Safety Assessment Market?

What Defines the Pharmaceutical Safety Assessment Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Pharmaceutical Safety Assessment Industry?

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions